IMR-1A
|
I412257-50mg
|
≥97% |
331862-41-0 |
50mg
|
¥ 880.9
|
现货 |
阿拉丁 |
IMR-1A
|
I412257-25mg
|
≥97% |
331862-41-0 |
25mg
|
¥ 518.9
|
现货 |
阿拉丁 |
IMR-1A
|
I412257-250mg
|
≥97% |
331862-41-0 |
250mg
|
¥ 3003.9
|
现货 |
阿拉丁 |
IMR-1A
|
I412257-100mg
|
≥97% |
331862-41-0 |
100mg
|
¥ 1501.9
|
现货 |
阿拉丁 |
8-异15-酮基前列腺素E2
|
I393058-500μg
|
A solution in methyl acetate |
N/A |
500μg
|
¥ 587.9
|
期货,请咨询 |
阿拉丁 |
8-异15-酮基前列腺素E2
|
I393058-100μg
|
A solution in methyl acetate |
N/A |
100μg
|
¥ 133.9
|
期货,请咨询 |
阿拉丁 |
前列腺素F2α乙醇酰胺
|
I392115-1mg
|
Moligand™, ≥98%, 10mg/ml in ethanol |
353787-70-9 |
1mg
|
¥ 1499.9
|
期货,请咨询 |
阿拉丁 |
吲哚美辛庚酯
|
I380997-5mg
|
A solution in methyl acetate |
N/A |
5mg
|
¥ 753.9
|
期货,请咨询 |
阿拉丁 |
吲哚美辛庚酯
|
I380997-1mg
|
A solution in methyl acetate |
N/A |
1mg
|
¥ 168.9
|
期货,请咨询 |
阿拉丁 |
9-异丙基-9H-咔唑
|
I346304-25g
|
≥97% |
1484-09-9 |
25g
|
¥ 1399.9
|
期货,请咨询 |
阿拉丁 |
9-异丙基-9H-咔唑
|
I346304-1g
|
≥97% |
1484-09-9 |
1g
|
¥ 114.9
|
期货,请咨询 |
阿拉丁 |
INH1
|
I341876-250mg
|
≥98% |
313553-47-8 |
250mg
|
¥ 1398.9
|
现货 |
阿拉丁 |
INH1
|
I341876-100mg
|
≥98% |
313553-47-8 |
100mg
|
¥ 822.9
|
现货 |
阿拉丁 |
吲哚-3-丙酮
|
I341539-25g
|
≥97% |
1201-26-9 |
25g
|
¥ 783.9
|
现货 |
阿拉丁 |
咪唑并[1,2-a]吡啶-3-羧酸
|
I341532-5g
|
≥98% |
6200-60-8 |
5g
|
¥ 213.9
|
现货 |
阿拉丁 |
咪唑并[1,2-a]吡啶-3-羧酸
|
I341532-25g
|
≥98% |
6200-60-8 |
25g
|
¥ 769.9
|
现货 |
阿拉丁 |
咪唑并[1,2-a]吡啶-3-羧酸
|
I341532-100g
|
≥98% |
6200-60-8 |
100g
|
¥ 4305.9
|
期货,请咨询 |
阿拉丁 |
IM-12
|
I340238-50mg
|
Moligand™, ≥95% |
1129669-05-1 |
50mg
|
¥ 1414.9
|
现货 |
阿拉丁 |
IM-12
|
I340238-25mg
|
Moligand™, ≥95% |
1129669-05-1 |
25mg
|
¥ 808.9
|
现货 |
阿拉丁 |
IM-12
|
I340238-100mg
|
Moligand™, ≥95% |
1129669-05-1 |
100mg
|
¥ 2059.9
|
现货 |
阿拉丁 |
吲哚瑞酯 盐酸盐
|
I337663-500mg
|
≥95% |
72318-55-9 |
500mg
|
¥ 6487.9
|
现货 |
阿拉丁 |
吲哚瑞酯 盐酸盐
|
I337663-250mg
|
≥95% |
72318-55-9 |
250mg
|
¥ 3985.9
|
现货 |
阿拉丁 |
吲哚瑞酯 盐酸盐
|
I337663-100mg
|
≥95% |
72318-55-9 |
100mg
|
¥ 2038.9
|
现货 |
阿拉丁 |
铁(II)钛氧化物
|
I333605-10g
|
≥99% |
12022-71-8 |
10g
|
¥ 823.9
|
现货 |
阿拉丁 |